Study on the preliminary safety and efficacy of ARC Therapy using the ARC-IM Lumbar System to support the mobility of individuals with a chronic spinal cord injury (BoxSwitch)
Zusammenfassung der Studie
This study aims to evaluate the preliminary safety and efficacy of ARC Therapy, which uses an implantable spinal cord electrical stimulation system, with the goal of promoting mobility and potentially improving other clinical functions such as spasticity following a chronic spinal cord injury. The study will assess the safety of using the system and associated procedures to properly integrate it into standard clinical rehabilitation programs. It will also evaluate the safety and efficacy of the therapy in the short and long term on mobility, spasticity, bowel, urinary, and sexual functions, as well as quality of life.
(BASEC)
Untersuchte Intervention
In this study, participants who have completed the STIMO study protocol (SNCTP000001953) will be offered to replace their currently implanted Activa RC stimulator with the ARC-IM IPG to demonstrate that the expanded set of stimulation capabilities can be integrated into the personalization of the SCS protocols. The aim is to improve the efficiency of lower limb motor activities while simplifying the personal use of the system at home. Additionally, under certain conditions (current status of implanted devices, technical and surgical compatibility) and evaluated on a case-by-case basis, this study provides for a strategy to replace the stimulation lead.
(BASEC)
Untersuchte Krankheit(en)
Spinal cord injury
(BASEC)
- Completion of the main phase of the STIMO study (NCT02936453) and improvement in at least one of the primary or secondary evaluation criteria (WISCI II score, 10-meter walk test (10MWT), weight-bearing capacity test (Weight Bearing Capacity), SCIM III score, or 6-minute walk test (6MWT)) - Age 18-65 years - Spinal cord injury classified according to the AIS scale (American Spinal Injury Association Impairment Scale) A, B, C, and D. - Spinal cord injury older than 12 months - Spinal cord injury above T10, with preservation of conus functions - Spinal cord injury caused by trauma - Stable physical and psychological medical condition as assessed by investigators - Able to understand and interact in French or English with the study team - Agrees to comply in good faith with all study conditions and to attend all scheduled appointments - Must provide and sign informed consent prior to any study-related procedure (BASEC)
Ausschlusskriterien
- Diseases and conditions that would increase morbidity and mortality of spinal cord injury surgery - History of myocardial infarction or stroke within the last 6 months - Limitation of walking function due to accompanying disorders (CNS) (systemic malignant diseases, cardiovascular disorders limiting physical training, peripheral nerve disorders) - Any active implanted cardiac device, such as a pacemaker or defibrillator - Any indication requiring diathermy - Any indication requiring MRI - Any anatomical limitation in the implantation area at the discretion of the investigators - Other conditions that would render the subject unable to participate in the tests at the discretion of the investigators - Clinically significant mental illness at the discretion of the investigators - Presence of an intrathecal baclofen pump or insulin pump - Other clinically significant concomitant pathological states (e.g., renal failure, liver dysfunction, cardiovascular disease, etc.) - Inability to follow study procedures, e.g., due to language issues, psychological disorders, or participant dementia - Inclusion of the investigator, family members, employees, and other dependents - Pregnant women (pregnancy test mandatory for women of childbearing age) or breastfeeding women (BASEC)
Studienstandort
Lausanne
(BASEC)
Sponsor
-
(BASEC)
Kontakt für weitere Auskünfte zur Studie
Kontaktperson Schweiz
Prof. Grégoire Courtine
+41 21 69 30762
gregoire.courtine@clutterepfl.chEPFL
(BASEC)
Wissenschaftliche Auskünfte
nicht verfügbar
Name der bewilligenden Ethikkommission (bei multizentrischen Studien nur die Leitkommission)
Ethikkommission Waadt
(BASEC)
Datum der Bewilligung durch die Ethikkommission
24.08.2023
(BASEC)
ICTRP Studien-ID
nicht verfügbar
Offizieller Titel (Genehmigt von der Ethikkommission)
Study on preliminary safety and efficacy of the ARC Therapy using the ARC-IM Lumbar System to support mobility in people with chronic spinal cord injury (BASEC)
Wissenschaftlicher Titel
nicht verfügbar
Öffentlicher Titel
nicht verfügbar
Untersuchte Krankheit(en)
nicht verfügbar
Untersuchte Intervention
nicht verfügbar
Studientyp
nicht verfügbar
Studiendesign
nicht verfügbar
Ein-/Ausschlusskriterien
nicht verfügbar
nicht verfügbar
Primäre und sekundäre Endpunkte
nicht verfügbar
nicht verfügbar
Registrierungsdatum
nicht verfügbar
Einschluss des ersten Teilnehmers
nicht verfügbar
Sekundäre Sponsoren
nicht verfügbar
Weitere Kontakte
nicht verfügbar
Sekundäre IDs
nicht verfügbar
Angaben zur Verfügbarkeit von individuellen Teilnehmerdaten
nicht verfügbar
Weitere Informationen zur Studie
nicht verfügbar
Ergebnisse der Studie
Zusammenfassung der Ergebnisse
nicht verfügbar
Link zu den Ergebnissen im Primärregister
nicht verfügbar